Literature DB >> 24574408

Local control of repeated-dose rectal challenges in DNA/MVA-vaccinated macaques protected against a first series of simian immunodeficiency virus challenges.

Sunil Kannanganant1, Salaija Gangadhara, Lilin Lai, Benton Lawson, Pamela A Kozlowski, Harriet L Robinson, Rama Rao Amara.   

Abstract

Here, we report the results of a late boost and three additional series of simian immunodeficiency virus (SIV) challenges in seven DNA/modified vaccinia virus Ankara (MVA)-vaccinated rhesus macaques who resisted a first series of rectal challenges. During 29 additional challenges delivered over 2.3 years, all animals became infected. However, 13 blips of virus in six macaques and anamnestic Env-specific rectal IgA responses in three of the six suggested that local control of infections was occurring during the serial challenge.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574408      PMCID: PMC4019109          DOI: 10.1128/JVI.00145-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

1.  Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.

Authors:  Sunil Kannanganat; Pragati Nigam; Vijayakumar Velu; Patricia L Earl; Lilin Lai; Lakshmi Chennareddi; Benton Lawson; Robert L Wilson; David C Montefiori; Pamela A Kozlowski; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

Review 2.  The 'immunologic advantage' of HIV-exposed seronegative individuals.

Authors:  Masaaki Miyazawa; Lucia Lopalco; Francesco Mazzotta; Sergio Lo Caputo; Francisco Veas; Mario Clerici
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

3.  Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine.

Authors:  Lilin Lai; Suefen Kwa; Pamela A Kozlowski; David C Montefiori; Guido Ferrari; Welkin E Johnson; Vanessa Hirsch; Francois Villinger; Lakshmi Chennareddi; Patricia L Earl; Bernard Moss; Rama Rao Amara; Harriet L Robinson
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 4.  Protective immunity against HIV infection: has nature done the experiment for us?

Authors:  G M Shearer; M Clerici
Journal:  Immunol Today       Date:  1996-01

5.  Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

6.  Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.

Authors:  Morgane Bomsel; Daniela Tudor; Anne-Sophie Drillet; Annette Alfsen; Yonatan Ganor; Marie-Gaëlle Roger; Nicolas Mouz; Mario Amacker; Anick Chalifour; Lorenzo Diomede; Gilles Devillier; Zhe Cong; Qiang Wei; Hong Gao; Chuan Qin; Gui-Bo Yang; Rinaldo Zurbriggen; Lucia Lopalco; Sylvain Fleury
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

7.  Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.

Authors:  L Dorrell; A J Hessell; M Wang; H Whittle; S Sabally; S Rowland-Jones; D R Burton; P W Parren
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

8.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.

Authors:  S Mazzoli; D Trabattoni; S Lo Caputo; S Piconi; C Blé; F Meacci; S Ruzzante; A Salvi; F Semplici; R Longhi; M L Fusi; N Tofani; M Biasin; M L Villa; F Mazzotta; M Clerici
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

9.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.

Authors:  S Rowland-Jones; J Sutton; K Ariyoshi; T Dong; F Gotch; S McAdam; D Whitby; S Sabally; A Gallimore; T Corrah
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.

Authors:  Michael Lopker; Juliet Easlick; Sarah Sterrett; Julie M Decker; Hannah Barbian; Gerald Learn; Brandon F Keele; James E Robinson; Hui Li; Beatrice H Hahn; George M Shaw; Katharine J Bar
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

View more
  6 in total

Review 1.  Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.

Authors:  Lynette Siv Chea; Rama Rao Amara
Journal:  Expert Rev Vaccines       Date:  2017-09-04       Impact factor: 5.217

2.  CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.

Authors:  Suefen Kwa; Lilin Lai; Sailaja Gangadhara; Mariam Siddiqui; Vinod B Pillai; Celia Labranche; Tianwei Yu; Bernard Moss; David C Montefiori; Harriet L Robinson; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.

Authors:  Tiffany M Styles; Sailaja Gangadhara; Pradeep B J Reddy; Sakeenah Hicks; Celia C LaBranche; David C Montefiori; Cynthia A Derdeyn; Pamela A Kozlowski; Vijayakumar Velu; Rama Rao Amara
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.

Authors:  Sunil Kannanganat; Linda S Wyatt; Sailaja Gangadhara; Venkatesarlu Chamcha; Lynette S Chea; Pamela A Kozlowski; Celia C LaBranche; Lakshmi Chennareddi; Benton Lawson; Pradeep B J Reddy; Tiffany M Styles; Thomas H Vanderford; David C Montefiori; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  J Immunol       Date:  2016-09-28       Impact factor: 5.422

5.  Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.

Authors:  Kara Jensen; Rafiq Nabi; Koen K A Van Rompay; Spencer Robichaux; Jeffrey D Lifson; Michael Piatak; William R Jacobs; Glenn Fennelly; Don Canfield; Katie R Mollan; Michael G Hudgens; Michelle H Larsen; Angela M Amedee; Pamela A Kozlowski; Kristina De Paris
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.

Authors:  Julie A Ake; Alexandra Schuetz; Poonam Pegu; Lindsay Wieczorek; Michael A Eller; Hannah Kibuuka; Fredrick Sawe; Leonard Maboko; Victoria Polonis; Nicos Karasavva; David Weiner; Arthur Sekiziyivu; Josphat Kosgei; Marco Missanga; Arne Kroidl; Philipp Mann; Silvia Ratto-Kim; Leigh Anne Eller; Patricia Earl; Bernard Moss; Julie Dorsey-Spitz; Mark Milazzo; G Laissa Ouedraogo; Farrukh Rizvi; Jian Yan; Amir S Khan; Sheila Peel; Niranjan Y Sardesai; Nelson L Michael; Viseth Ngauy; Mary Marovich; Merlin L Robb
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.